E. M. Schneider

581 total citations
31 papers, 467 citations indexed

About

E. M. Schneider is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, E. M. Schneider has authored 31 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 6 papers in Oncology and 6 papers in Hematology. Recurrent topics in E. M. Schneider's work include Immune Cell Function and Interaction (17 papers), T-cell and B-cell Immunology (15 papers) and Immunotherapy and Immune Responses (10 papers). E. M. Schneider is often cited by papers focused on Immune Cell Function and Interaction (17 papers), T-cell and B-cell Immunology (15 papers) and Immunotherapy and Immune Responses (10 papers). E. M. Schneider collaborates with scholars based in Germany, Netherlands and India. E. M. Schneider's co-authors include Graham Pawelec, Peter Wernet, Arnika Rehbein, Gerhard Ehninger, Dieter Volkmann, Torsten Tonn, Charlotte Esser, M. Hadam, Ernst Gleichmann and Andreas Sievers and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Cancer.

In The Last Decade

E. M. Schneider

31 papers receiving 429 citations

Peers

Countries citing papers authored by E. M. Schneider

Since Specialization

Citations

This map shows the geographic impact of E. M. Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. M. Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. M. Schneider more than expected).

Fields of papers citing papers by E. M. Schneider

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. M. Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. M. Schneider. The network helps show where E. M. Schneider may publish in the future.

Co-authorship network of co-authors of E. M. Schneider

This figure shows the co-authorship network connecting the top 25 collaborators of E. M. Schneider. A scholar is included among the top collaborators of E. M. Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. M. Schneider. E. M. Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Functional Characteristics of Human Peripheral Blood α/βTCR+, CD4‐ and CD8‐Double‐Negative (DN) T Cells 1999 ·Microbiology and Immunology ·Tim Niehues, (unknown), E. M. Schneider	6
2	Persistence of decreased T-helper cell function in industrial workers 20 years after exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1996 ·Environmental Health Perspectives ·Torsten Tonn, Charlotte Esser, E. M. Schneider, (unknown), Ernst Gleichmann	35
3	T-Cells as Antigen-Presenting Cells - a Function of Human Peripheral Double-Negative T-Cells 1995 ·Experimental Hematology ·Tim Niehues, (unknown), W.J.M. Tax, E. M. Schneider	1
4	Clinical trial of natural human lymphocyte-derived interleukin 2 in cancer patients: Effects on cytokine production and suppressor cell status 1991 ·Biotherapy ·Graham Pawelec, Heinz‐Josef Lenz, E. M. Schneider, Hans‐Jörg Bühring, Arnika Rehbein, Petra Baumgärtner, Gerhard Ehninger	2
5	Partial correction of defective generation of lymphokine-activated killer cells in patients with chronic myelogenous leukaemia after in vivo treatment with interferon-? (wellferon) 1989 ·Cancer Immunology Immunotherapy ·Graham Pawelec, E. M. Schneider, Gerhard Ehninger, Arnika Rehbein, Helmut Schmidt	18
6	T and B Cell Specific Immune Responses to Purified Protein Derivative in the Cerebrospinal Cavity May be Maintained and Regulated Independently of Systemic Immune Control 1988 ·Scandinavian Journal of Immunology ·E. M. Schneider, (unknown), (unknown), Cosima Zimmermann, Johannes Dichgans, W. Schlote, Peter Wernet	2
7	Cellular immunological defects of chronic myelogenous leukaemics: partial dependence on busulphan therapy 1988 ·Cancer Immunology Immunotherapy ·Graham Pawelec, (unknown), E. M. Schneider, (unknown), Gerhard Ehninger	13
8	DY determinants, possibly associated with novel class II molecules, stimulate autoreactive CD4+ T cells with suppressive activity. 1988 ·The Journal of Experimental Medicine ·Graham Pawelec, Nelson Fernández, Thomas Brocker, E. M. Schneider, H. Festenstein, Peter Wernet	24
9	HLA‐DP in rheumatoid arthritis 1988 ·Tissue Antigens ·Graham Pawelec, P. Reekers, D. Brackertz, David M. Sansom, E. M. Schneider, (unknown), Claude P. Muller, Arnika Rehbein, (unknown), Peter Wernet	27
10	Human leukocyte antigen-DP in leukemia 1988 ·Cancer ·Graham Pawelec, Gerhard Ehninger, Claudia Müller, (unknown), E. M. Schneider, Peter Wernet	12
11	HIGH FREQUENCY OF GRAFT-VERSUS-HOST-LIKE SYNDROMES FOLLOWING SYNGENEIC BONE MARROW TRANSPLANTATION 1988 ·Transplantation ·H. Einsele, Gerhard Ehninger, E. M. Schneider, (unknown), Angelika Vallbracht, R. Dopfer, Henk G. Schmidt, (unknown), Claudia A. Müller	36
12	Modulation of in vitro myelopoiesis by alloreactive T cell clones 1986 ·Annals of Hematology ·F.W. Busch, Peter Wernet, Peter Meyer, E. M. Schneider, Graham Pawelec	5
13	Functionally distinct human T-lymphocyte clones sharing potent suppressive activity on immunoglobulin secretion. 1985 ·PubMed ·Fiorenza Falcioni, Graham Pawelec, Norbert W. Brattig, E. M. Schneider, P. A. Berg, Peter Wernet	4
14	Alloproliferative human T cell clones primed and cultured in vitro lose proliferative and gain suppressive activity with age 1984 ·Human Immunology ·Graham Pawelec, Peter Wernet, Arnika Rehbein, (unknown), E. M. Schneider	9
15	Strong lymphoproliferative suppressive function of PLT clones specific for SB-like antigens 1984 ·Human Immunology ·Graham Pawelec, Peter Wernet, (unknown), (unknown), E. M. Schneider	15
16	Human T-cell clones with multiple and changing functions: indications of unexpected flexibility in immune response networks? 1983 ·Immunology Today ·Graham Pawelec, E. M. Schneider, Peter Wernet	31
17	Alloactivated long‐term cultured human T lymphocytes express both HLA‐DR and SB antigens but lack lymphocyte stimulation capacity 1982 ·European Journal of Immunology ·Graham Pawelec, (unknown), E. M. Schneider, Stephen Shaw, Peter Wernet	22
18	Clonally restricted natural killer-like cytotoxicity displayed by cloned human T cell lines. 1982 ·The Journal of Immunology ·Graham Pawelec, M. Hadam, E. M. Schneider, Peter Wernet	26
19	Concanavalin A binds to the endoplasmic reticulum and the starch grain surface of root statocytes 1981 ·Planta ·E. M. Schneider, Andreas Sievers	9
20	Biochemical properties of potato phosphorylase change with its intracellular localization as revealed by immunological methods 1981 ·Planta ·E. M. Schneider, (unknown), Dieter Volkmann	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact